当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 利润表

康辰药业

(603590)

  

流通市值:30.78亿  总市值:59.07亿
流通股本:8336.76万   总股本:1.60亿

利润表

按照会计年度查询:
报告期2020-09-302020-06-302020-03-312019-12-31
一、营业总收入550,025,351.3348,003,365.3370,929,823.491,065,924,550.73
营业收入550,025,351.3348,003,365.3370,929,823.491,065,924,550.73
二、营业总成本426,037,165.61258,857,569.2647,769,295.88798,994,056.21
营业成本38,772,922.4323,339,123.336,114,751.8357,661,913.86
营业税金及附加8,727,630.375,176,892.111,379,064.9215,761,633
销售费用317,979,367.52201,583,583.7832,313,358637,204,763.14
管理费用38,906,443.8622,826,308.9310,053,832.141,847,231.94
财务费用-39,916,385.67-31,390,246.37-15,716,535.42-62,266,283.9
资产减值损失-------13,902,231.99
三、其他经营收益190,603,979.78157,589,484.3119,448,365.9959,236,093.25
允许价值变动净收益26,541.7426,541.7414,817.773,419.49
投资净收益11,640,477.4711,639,331.862,604.818,908,893.04
联营、合营企业投资收益5,679.154,533.542,604.8112,319.7
汇兑净收益--------
四、营业利润159,897,228.49116,883,186.5237,159,105.11299,511,314.47
营业外收入3,129.092,115.747264,364.13
营业外支出1,595,612.771,333,523.631,318,291.29424,401.45
非流动资产处置净损失--------
五、利润总额158,304,744.81115,551,778.6335,841,539.82299,091,277.15
所得税16,546,689.3712,495,655.13,608,054.7833,011,135.09
未确认的投资损失--------
六、净利润(百万元)141.76103.0632.23266.08
少数股东损益--------
归属于母公司股东的净利润141,758,055.44103,056,123.5332,233,485.04266,080,142.06
七、每股收益0.890.640.21.66
基本每股收益0.890.640.21.66
稀释每股收益0.890.640.21.66
TOP↑